Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hideo Machimura"'
Autor:
Kouta Aoyama, Shun Ito, Masaaki Miyakawa, Kouichi Tamura, Nobumichi Saito, Tomoya Umezono, Shinichi Umezawa, Toshimasa Hishiki, Fuyuki Minagawa, Hareaki Yamamoto, Masao Toyoda, Daisuke Suzuki, Kazuo Kobayashi, Keiichi Chin, Masahiro Takihata, Togo Aoyama, Kazuyoshi Sato, Hiroshi Takeda, Hideo Machimura, Yutaka Hatori, Hisakazu Degawa, Takayuki Furuki, Kohsuke Minamisawa, Masahiro Hayashi, Yoshiro Hamada, Hiroyuki Sakai, Yoshiro Suzuki, Tomohiko Kanaoka, Akira Kanamori, Nobuo Hatori
Publikováno v:
Diabetes Technology & Therapeutics. 23:110-119
Aim: Sodium–glucose cotransporter 2 inhibitors (SGLT2is) provide renal protection in patients with type 2 diabetes mellitus (T2DM). The aim of this study was to elucidate the renal effects of long-...
Autor:
Hareaki Yamamoto, Akira Kanamori, Daisuke Suzuki, Masao Toyoda, Nobuo Hatori, Hisakazu Degawa, Kazuyoshi Sato, Takayuki Furuki, Hiroyuki Sakai, Kouta Aoyama, Kouichi Tamura, Keiichi Chin, Masahiro Takihata, Shun Ito, Fuyuki Minagawa, Masahiro Hayashi, Toshimasa Hishiki, Kohsuke Minamisawa, Yoshiro Suzuki, Hiroshi Takeda, Togo Aoyama, Hideo Machimura, Yutaka Hatori, Shinichi Umezawa, Masaaki Miyakawa, Yoshiro Hamada, Tomoya Umezono, Kazuo Kobayashi
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction Sodium–glucose cotransporter 2 inhibitors (SGLT2i) improve renal outcome in patients with type 2 diabetes mellitus, but the mechanism is not fully understood. The aim of this retrospective study was to assess the association of ac
Autor:
Akira Kanamori, Masahiro Takihata, Kotaro Iemitsu, Hikaru Amemiya, Mizuki Kaneshiro, Yoko Matsuzawa, Masashi Ishikawa, Keiji Tanaka, Hiroshi Takeda, Kazuaki Shinoda, Akira Kubota, Takehiro Kawata, Tetsuo Takuma, Nobuaki Minami, Yasushi Tanaka, Hideo Machimura, Ikuro Matsuba, Atsuko Mokubo, Masaaki Miyakawa, Masahiko Takai, Yasuo Terauchi, Syogo Ito, Taro Asakura, Fuyuki Minagawa
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 5, Pp 1248-1257 (2020)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long‐term treatments are available. Methods This was an investigator‐initiated multicenter prospective intervention study in which ipra
Autor:
Toshimasa Hishiki, Akira Kanamori, Atsuko Mokubo, Kouta Aoyama, Hidetoshi Shimura, Nobuo Hatori, Shinichi Nakajima, Daisuke Suzuki, Takayuki Furuki, Tomoya Umezono, Moritsugu Kimura, Masao Toyoda, Kazuo Kobayashi, Keiichi Chin, Masahiro Takihata, Hisakazu Degawa, Hiroshi Takeda, Mitsuo Obana, Shun Ito, Kazuyoshi Sato, Masaaki Miyakawa, Togo Aoyama, Hareaki Yamamoto, Hiroyuki Sakai, Shinichi Umezawa, Hideo Machimura
Publikováno v:
Diabetes and Vascular Disease Research. 16:103-107
The aim of this study was to assess the renal effects of the glucose-lowering SGLT2 inhibitors in Japanese type 2 diabetes mellitus patients with chronic kidney disease.The Kanagawa Physicians Association maintains a registry of patients who visit th
Autor:
Atsuko Mokubo, Hidetoshi Shimura, Noriko Kaneyama, Hideo Machimura, Shinichi Umezawa, Togo Aoyama, Keiichi Chin, Mitsuo Obana, Akira Kanamori, Masahiro Takihata, Toshimasa Hishiki, Nobuo Hatori, Hiroyuki Sakai, Shinichi Nakajima, Daisuke Suzuki, Tomoya Umezono, Kouta Aoyama, Kazuo Kobayashi, Hisakazu Degawa, Masao Toyoda, Shun Ito, Masaaki Miyakawa, Hareaki Yamamoto, Takayuki Furuki, Hiroshi Takeda
Publikováno v:
Journal of Diabetes Research, Vol 2019 (2019)
Journal of Diabetes Research
Journal of Diabetes Research
Aim. The renoprotective effect of sodium-glucose cotransporter 2 inhibitors is thought to be due, at least in part, to a decrease in blood pressure. The aim of this study was to determine the renal effects of these inhibitors in low blood pressure pa